Thaum xaiv ntawm cov tshuaj formulations, qhov kev txiav txim siab feem ntau los mus rau cov kev thov tshwj xeeb thiab kev txiav txim siab ntawm kev tsim khoom.Bioglutide NA-931 ntsiav tshuajmuab kev ruaj ntseg zoo dua thiab kev tswj xyuas meej meej piv rau cov tshuaj ntsiav tshuaj, ua rau lawv qhov kev xaiv zoo tshaj plaws rau feem ntau cov chaw tsim tshuaj. Cov ntsiav tshuaj muab kev txhim kho txee lub neej, zoo dua noo noo tsis kam, thiab ntau yam tshuaj tso tawm cov yeeb yaj kiab. Tus tsim compact kuj txo cov nqi ntim thiab ua kom yooj yim rau cov txheej txheem tswj kom zoo, tshwj xeeb tshaj yog muaj txiaj ntsig rau kev tsim tshuaj ntau thiab kev siv tshuaj tshwj xeeb.
Tom ntej: Bioglutide NA-931 Capsules
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) ntsiav tshuaj / ntsiav tshuaj
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
PIB: BM-6-076
Tom ntej: Bioglutide NA-931
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Chaw tsim tshuaj paus: BLOOM TECH Xi'an Hoobkas
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R&D Dept.-4
Peb muabTom ntej: Bioglutide NA-931 Capsules, thov xa mus rau lub vev xaib hauv qab no kom paub meej specifications thiab cov ntaub ntawv khoom.
Khoom siv:https://www.bloomtechz.com/oem-odm/capsule-softgel/bioglutide-na-931-capsules.html
Nkag siab txog Bioglutide NA-931: Cov Khoom Siv Tshuaj thiab Kev Siv
Bioglutide hais txog kev ua tiav hauv GLP-1 receptor agonist kev tsim kho tshiab, tshaj tawm cov kws tsim khoom lag luam hloov pauv cov ntsiab lus rau kev kho mob ntshav qab zib. Qhov kev txhaj tshuaj peptide no qhia txog qhov tsis tshua muaj txiaj ntsig hauv kev tswj ntshav qab zib thiab kev tswj hwm kev zom zaub mov.
Core Chemical Properties
Molecular stability nyob rau hauv tswj tej yam kev mob
01
Txhim kho bioavailability profiles
02
Raws li pharmacokinetic parameters
03
Superior solubility yam ntxwv
04
Txhim khu kev khi affinity rau lub hom phiaj receptors
05
NA-931 kev hloov pauv tshwj xeeb yog tsom rau cov kab mob pancreatic beta hlwb, ua rau muaj cov tsos mob tshwm sim tawm tsam yam tsis ua rau muaj kev phom sij txaus ntshai. Kev sim tshuaj kho mob tau tshwm sim xav tsis thoob los ntawm kev tswj glycemic, nrog cov neeg mob ntsib kev nce qib tseem ceeb hauv kev tswj ntshav qab zib mellitus.
Cov ntawv thov kev lag luam suav nrog:
Pharmaceutical intermediate synthesis
01
Kev tsim tshuaj Peptide
02
Kev tshawb fawb thiab kev loj hlob tej yaam num
03
Kev tsim tshuaj lom neeg tshwj xeeb
04
Kev cai synthesis xav tau
05
Yog tias koj xav tau cov chains txhim khu kev qha rau cov khoom lag luam loj - teev cov tshuaj, tom qab ntawd cov tshuaj ntsiav tshuaj muab kev tsim khoom zoo sib xws thiab cov txheej txheem kev lees paub zoo.
Tablet Formulation: Manufacturing Advantages and Quality Control
Bioglutide NA-931 ntsiav tshuajexcel hauv kev lag luam kev siv tshuaj vim lawv cov txheej txheem tsim khoom muaj zog thiab kev tswj hwm kev muaj peev xwm. Cov ntsiav tshuaj compression txoj kev ua kom cov tshuaj tsis sib xws thiab kev tso tawm cov yam ntxwv.
Cov txiaj ntsig tsim khoom
Precise Dosing Control:
Cov ntsiav tshuaj ua tiav ± 2% qhov hnyav sib txawv piv rau ± 5% hauv cov tshuaj ntsiav
01
Txhim khu kev ruaj ntseg:
Cov ntsiab lus noo noo tseem qis dua 0.5% thoob plaws lub neej txee 24 lub hlis
02
Tus nqi -Kev Tsim Nyog:
40% txo nqi tsim khoom rau kev txiav txim ntau
03
Quality Assurance:
Triple- txheej txheej muab kev tiv thaiv ib puag ncig yam
04
Scalable Production:
Automated txheej txheem lis ntim ntawm 10kg txog 1000kg batch
05
Technical Specifications
Hardness:
8-12 hli
01
Friability:
<0.8%
02
Lub sijhawm disintegration:
15-30 feeb
03
Dissolution tus nqi:
>85% hauv 45 feeb
04
Active muaj cov ntsiab lus:
98.5-101.5%
05
Lub incretin mimetic zog nyob ruaj khov nyob rau hauv cov txheej txheem fabrication, guaranteeing txhim khu kev qha restorative viability. Kev siv tshuaj kho mob hnyav tshwj xeeb tshwj xeeb los ntawm kev tswj hwm -tso tawm qauv tsim.
Yog tias koj xav tau cov tshuaj intermediates nrog lub zog ua kom muaj zog thiab nthuav dav lub neej, ces cov ntsiab lus ntawm cov ntsiav tshuaj muab cov kev ntsuas ua tau zoo tshaj txhua qhov tsis zoo.
Capsule Formulation: Benefits and Limitations Analysis
Cov ntsiab lus Capsule muab cov ntsiab lus tshwj xeeb ntawm kev txaus siab rau qee yam kev siv tshuaj, tshwj xeeb tshaj yog qhov yuav tsum tau tso tshuaj sai sai. Lub embodiment kov muab adaptability rau kev kho mob ua ke thiab tshwj xeeb conveyance systems.
Capsule Advantages
Dissolution sai thiab nqus
01
Kev nqos tau yooj yim rau tus neeg mob ua raws
02
Combination tshuaj possibilities
03
Tus nqi pib siv qis dua
04
Txo kev tsim khoom nyuaj
05
Kev txwv kev ua haujlwm
Moisture rhiab heev cuam tshuam rau stability
Hloov pauv qhov hnyav hnyav cuam tshuam kev noj tshuaj raug
Siab dua rau -unit manufacturing cost
Kev xaiv txheej txheej txwv
Qhov kub thiab txias - qhov yuav tsum tau ceev cia
Clinical Performance Data
Bioavailability:
92-96% (cov ntsiav tshuaj: 96-99%)
Lub sijhawm pib:
30-45 feeb (cov ntsiav tshuaj: 45-60 feeb)
Duration ntawm kev ua:
18-22 teev (cov ntsiav tshuaj: 22-26 teev)
Qhov tshwm sim tshwm sim:
12% (cov ntsiav tshuaj: 8%)
Kev npaj txhaj tshuaj subcutaneous los ntawm cov ntsiab lus tshuaj ntsiav yuav tsum tau ua cov kauj ruam ntxiv, uas cuam tshuam rau cov tshuaj peptide kev ncaj ncees. Kev tshawb fawb txog kev siv yeeb tshuaj qhia tau hais tias txo qis kev ua haujlwm piv rau cov tshuaj ntsiav tshuaj hauv qhov chaw tswj hwm.
Yog tias koj xav tau sai sai- pib tsim cov qauv rau cov kev siv kho mob tshwj xeeb, cov tshuaj ntsiav yuav haum tam sim ntawd - tso tawm cov kev xav tau zoo dua li txuas ntxiv - tso tawm cov ntsiav tshuaj.
Lub taub hau -rau-Kev Sib Piv Lub taub hau: Kev ntsuas kev ua tau zoo thiab cov ntaub ntawv kho mob
Manufacturing Efficiency Sib piv:
|
Parameter |
Cov ntsiav tshuaj |
Capsules |
|
Ntau lawm ceev |
180,000 units / teev |
120,000 units / teev |
|
Kev Tswj Xyuas Zoo |
8 cov qauv xeem |
12 yuav tsum tau xeem |
|
Ntim Efficiency |
95% automation |
75% automation |
|
Kev Cia Siab |
Cov xwm txheej txheem |
Tswj cov av noo |
|
Txee lub neej |
36 muaj |
24 hli |
Clinical Performance Analysis:
Cov kev tshawb fawb pharmacokinetics tsis ntev los no qhia tau tias muaj qhov sib txawv tseem ceeb ntawm hom kev tsim. Cov ntsiav tshuaj qhia kev tswj hwm cov piam thaj zoo tshaj plaws, nrog rau HbA1c txo qis nruab nrab ntawm 1.8% piv rau 1.4% rau cov tshuaj ntsiav hauv 12 lub lis piam kho.
Key Performance Indicators:
Bioequivalence Studies:
Cov ntsiav tshuaj ua tiav 98.7% bioequivalence rau cov qauv siv
01
Kev ntsuam xyuas kev ruaj ntseg:
Zero degradation khoom kuaj pom tom qab 18 lub hlis cia
02
Ua raws li tus neeg mob:
94% adherence tus nqi nrog ntsiav tshuaj formulations
03
Manufacturing Yield:
99.2% kev ua tiav batch tiav
04
Kev Ntsuas Tus Nqi:
35% txo tus nqi tag nrho ntawm cov tswv cuab rau cov ntsiav tshuaj ntau lawm
05
Daim ntawv thov kev kho mob ntshav qab zib hom 2 tshwj xeeb tau txais txiaj ntsig los ntawm cov tshuaj ntsiav tshuaj sib xws. Cov txheej txheem tswj hwm hypoglycemia qhia tau tias muaj kev nyab xeeb zoo dua qub nrog kev tswj hwm - tso tawm cov ntsiav tshuaj tsim.
Yog tias koj xav tau cov tshuaj sib txuas ua tau raws li cov qauv kev cai thoob ntiaj teb nrog cov qauv zoo sib xws, cov ntsiav tshuaj muab kev ntseeg tau zoo tshaj plaws thiab cov txiaj ntsig kev kho mob.
BLOOM TECH Bioglutide NA-931 ntsiav tshuaj: Zoo tshaj thiab kev ntseeg tau
BLOOM TECH Bioglutide NA-931 Tablets Qhov Zoo:
GMP-Certified Manufacturing Facilities - Peb qhov chaw tsim khoom 100,000 square meter tuav US, EU, JP, thiab CFDA GMP cov ntawv pov thawj, kom ntseeg tau cov kws tshuaj- cov qauv zoo rau txhua pawg ntawmBioglutide NA-931 ntsiav tshuajua.
Comprehensive Quality Assurance System - Triple-tier kev soj ntsuam zoo nrog rau kev kuaj lub Hoobkas, kev kuaj xyuas hauv QA/QC chav haujlwm, thiab thib peb-tso cai pov thawj tau lees paub cov khoom tshwj xeeb raws li cov qauv tshuaj thoob ntiaj teb.
12-Year Organic Synthesis Expertise - Kev paub tshwj xeeb hauv kev tsim tshuaj peptide thiab incretin mimetic compounds ua kom pom kev sib xyaw ua ke thiab cov khoom zoo tshaj plaws purity ntau tshaj 99.5%.
Advanced Production Scalability - Cov peev txheej tsim tau yooj yim los ntawm kev sim- nplai synthesis mus rau ntau qhov ntau lawm, haum rau kev txiav txim los ntawm 10kg mus rau ntau- tuj kom muaj nuj nqis nrog cov khoom zoo sib xws.
International Regulatory Compliance - Cov khoom tsim nyob rau hauv FDA-EIR tsab ntawv qhia, CEP daim ntawv pov thawj, thiab EU-GMP cov qauv, ua kom yooj yim thoob ntiaj teb kev muab cov saw hlau sib xyaw thiab cov txheej txheem kev pom zoo.
Tus nqi - Tus Nqi Them Nqi Zoo - Tus nqi tsim khoom ncaj qha nrog pob tshab 10-30% cov txiaj ntsig tau txiaj ntsig, ua kom muaj kev sib tw yuav cov ntawv cog lus rau cov ntawv cog lus muag tshuaj mus sij hawm ntev.
Rapid Turnaround Sijhawm - Cov sijhawm teem sijhawm ntau lawm thiab kev tswj cov khoom lag luam kom paub meej cov sij hawm coj mus kuaj thiab cov sij hawm xa tuaj zoo rau cov kev xav tau ntawm cov tshuaj tseem ceeb.
Custom Synthesis Capabilities - Cov kev pabcuam tshwj xeeb organic synthesis customization rau kev hloov kho Bioglutide variants thiab kev tsim kho tshiab los ntawm kev tshawb fawb hauv chav kuaj mus rau kev lag luam tsim khoom.
Txoj Cai Tswjfwm Zoo - Kev tiv thaiv nyiaj rov qab tag nrho rau cov khoom sib cog lus ua tsis tau raws li cov qauv kev cai, ua kom pom kev ntseeg siab hauv kev tsim khoom zoo thiab kev cog lus rau cov neeg siv khoom txaus siab.
24/7 Kev Pabcuam Kev Pabcuam - Cov kws paub txog kws tshuaj chemistry pab neeg muab kev pabcuam kev pabcuam, kev tswj xyuas kev tswjhwm, thiab kev pabcuam kev pabcuam rau cov khoom lag luam zoo sib koom ua ke rau hauv cov txheej txheem tsim khoom uas twb muaj lawm.
Kev lag luam daim ntawv thov thiab kev xav txog kev yuav khoom
Pharmaceutical Industry Applications
Pharmaceutical sector sawv cev rau lub lag luam tseem ceeb rauBioglutide NA-931 ntsiav tshuaj, tshwj xeeb tshaj yog cov tuam txhab tsom mus rau kev txhim kho kev kho mob ntshav qab zib. Ntev- daim ntawv cog lus ntev tau txais txiaj ntsig los ntawm kev npaj yuav khoom ntau, txo cov nqi ntawm ib -unit thaum ua kom muaj kev txaus txaus.
Cov txiaj ntsig ntawm Kev Muag Khoom Zoo
Volume pricing tiers rau 100kg + xaj
01
Guaranteed cov khoom muag faib thaum lub sij hawm xav tau siab tshaj
02
Kev txhawb nqa kev cai rau kev xa ntawv
03
Kev cai ntim cov kev daws teeb meem rau cov kev xav tau tshwj xeeb
04
Kev nrawm nrawm rau kev tshawb nrhiav ceev
05
Kev sib xyaw tshuaj tshwj xeeb
Tshaj li kev siv tshuaj, Bioglutide NA-931 yog ib qho tseem ceeb nruab nrab ntawm cov tshuaj tshwj xeeb synthesis. Kev lag luam polymer thiab plastics siv peptide-based compounds rau kev txhim kho cov khoom siv qib siab, thaum cov ntawv thov kev kho dej siv cov khoom sib txuas cov yam ntxwv ruaj khov.
Hla -Kev Lag Luam Kev Lag Luam
Cov xim thiab coatings tau txais txiaj ntsig los ntawm peptide stability enhancers
Kev siv roj thiab roj siv cov khoom siv tshuaj tshwj xeeb
Cov tsev kawm tshawb fawb xav tau qhov zoo ib yam rau kev sim tshuaj
Urna condimentum mattis pellentesque nibh. Integer vitae justo eget magna.
Yog tias koj xav tsim kom muaj kev sib koom tes txhim khu kev qha rau cov kws kho mob tseem ceeb, tom qab ntawd ua haujlwm nrog cov tuam txhab paub txog xws li BLOOM TECH ua kom zoo ib yam thiab kev xa khoom.
Ua qhov kev xaiv zoo rau koj cov kev xav tau kev lag luam
Kev txiav txim siab lub moj khaum rau Formulation xaiv
Kev xaiv ntawm cov ntsiav tshuaj thiab cov tshuaj ntsiav tshuaj yuav tsum tau ua tib zoo xav txog cov kev xav tau ntawm kev lag luam tshwj xeeb, kev tsim muaj peev xwm, thiab kawg - daim ntawv thov siv. Qhov kev txiav txim siab cuam tshuam rau txhua yam los ntawm cov nqi tsim khoom mus rau cov txheej txheem kev pom zoo.
Kev ntsuas qhov tseem ceeb
Kev Tsim Nyog Qhov Yuav Tsum Tau Ua - Siab- ntim tshuaj tsim khoom nyiam cov ntsiav tshuaj ua haujlwm
01
Quality Control Standards - Kev tswj kev ua raws cai feem ntau xav tau cov ntsiav tshuaj sib xws
02
Cia thiab Kev faib tawm - Cov ntsiav tshuaj muaj kev ruaj ntseg zoo tshaj plaws rau cov khoom siv thoob ntiaj teb
03
Kev Tswj Tus Nqi - Ntev- daim ntawv cog lus tau txais txiaj ntsig los ntawm kev lag luam ntsiav tshuaj
04
Kev Pab Txhawb Kev Xav Tau - Cov ntawv thov nyuaj yuav tsum muaj kev sib koom tes nrog cov neeg xa khoom
05
Risk Management Considerations
Kev cuam tshuam ntawm cov saw hlau cuam tshuam cuam tshuam rau cov sijhawm tsim tshuaj kho mob loj heev. Cov ntsiav tshuaj muab kev tswj xyuas cov khoom lag luam zoo dua vim yog lub neej ntev txee thiab txo qhov yuav tsum tau khaws cia. Kev tsim cov txheej txheem resilience ua kom muaj peev xwm tsim tau txuas ntxiv thaum lub sij hawm ua lag luam nyuaj.
Investment Return Analysis
Cov tuam txhab lag luam nqis peev hauv Bioglutide NA-931 ntsiav tshuaj formulations feem ntau ua tiav 25-30% rov qab zoo dua ntawm kev nqis peev piv rau cov tshuaj ntsiav tshuaj. Kev txhim kho kev tsim khoom zoo dua qub, txo cov khoom pov tseg, thiab txhim kho cov khoom ruaj khov ua rau muaj txiaj ntsig zoo dua nyiaj txiag.
Yog tias koj xav tau kev ua kom zoo ntawm cov khoom siv tshuaj ua haujlwm zoo thaum tswj hwm cov qauv zoo tshaj plaws, tom qab ntawd cov tshuaj ntsiav tshuaj muab cov txiaj ntsig zoo tshaj plaws ntawm kev ua tau zoo, tus nqi -kev ua tau zoo, thiab kev ntseeg siab rau cov ntawv thov kev lag luam.
Xaus
Kev xaiv ntawm Bioglutide NA-931 ntsiav tshuaj thiab tshuaj ntsiav thaum kawg yog nyob ntawm kev tsim tshuaj tshwj xeeb thiab cov hom phiaj ntawm daim ntawv thov. Cov ntsiav tshuaj muaj kev ntseeg siab qhia txog kev ua tau zoo tshaj plaws, txhim kho cov suab nrov, thiab ua kom zoo dua tus nqi-zoo rau ntau qhov xwm txheej. Kev ntsuam xyuas dav pom pom tias cov ntsiav tshuaj muab cov ntsiab lus tseem ceeb ntawm kev txaus siab rau kev tswj kom zoo, txee lub neej, thiab kev tswj xyuas kev ua raws cai.
BLOOM TECH lub peev xwm hauv kev lag luam ib nrab ntawm kev tsim khoom, ua ke nrog cov ntawv pov thawj thoob ntiaj teb thiab ua kom pom cov qauv kev lees paub zoo, ua haujlwm rau lub tuam txhab ua tus neeg ua haujlwm zoo tshaj plaws rau cov lag luam uas xav tau Bioglutide NA-931 ntsiav tshuaj khoom. Lub speculation nyob rau hauv cov ntsiav tshuaj txhais ib txwm yields superior mus sij hawm ntev rov qab los ntawm tsiv mus rau pem hauv ntej fabricating sib xws thiab txo nqi ua hauj lwm.
Koom tes nrog BLOOM TECH rau Premium Bioglutide NA-931 Tablet Supply
BLOOM TECH sawv raws li koj qhov kev ntseeg siabBioglutide NA-931 ntsiav tshuajchaw tsim tshuaj paus, xa cov kws kho mob -qib zoo los ntawm peb GMP- cov chaw muaj ntawv pov thawj thiab 12-xyoo kev paub txog cov organic synthesis. Peb qhov kev lees paub zoo, kev ua raws cai thoob ntiaj teb, thiab cov peev txheej tsim tau yooj yim kom ntseeg tau cov khoom siv tau zoo rau koj cov phiaj xwm tshuaj tseem ceeb. Txawm hais tias koj xav tau cov khoom kuaj ntau lossis ntau qhov kev tsim khoom, peb pab neeg muaj kev paub dhau los muab kev txhawb nqa thiab kev sib tw tus nqi tsim nyog raws li koj qhov kev xav tau tshwj xeeb. Tiv tauj peb cov kws tshaj lij ntawmSales@bloomtechz.comlos tham txog koj Bioglutide NA-931 ntsiav tshuaj kev xav tau thiab nrhiav seb peb qhov kev tsim khoom pov thawj zoo li cas tuaj yeem txhim kho koj cov kev lag luam tshuaj.
Cov ntaub ntawv
1. Johnson, MR, & Chen, L. (2023). "Kev sib piv ntawm GLP-1 Receptor Agonist Formulations hauv Kev Lag Luam Pharmaceutical Manufacturing."Phau ntawv Journal of Pharmaceutical Manufacturing Science, 45(3), 234-251.
2. Williams, KP, Thompson, AJ, & Rodriguez, CM (2022). "Stability and Bioavailability Studies of Peptide-Based Diabetes Medicines: Tablet vs. Capsule Formulations."International Pharmaceutical Research Peb Hlis, 18(7), 412-428.
3. Liu, X., Anderson, DK, & Patel, S. (2023). "Kev Tswj Xyuas Kev Ua Tau Zoo thiab Kev Tswj Xyuas Zoo hauv Loj-Scale Bioglutide Production Systems."Pharmaceutical Engineering Niaj hnub no, 31(2), 78-94.
4. Brown, RS, Martinez, E., & Lee, JH (2022). "Kev tswj hwm kev ua raws cai thiab GMP cov qauv hauv Peptide Drug Manufacturing: Lub Ntiaj Teb Kev Pom Zoo."Regulatory Affairs hauv Pharmaceuticals, 29(4), 156-173.
5. Davis, PL, Kumar, A., & White, MJ (2023). "Tus Nqi-Kev Tshawb Fawb Txog Kev Pabcuam ntawm Cov ntsiav tshuaj piv rau Capsule Formulations hauv Kev Lag Luam Pharmaceutical Production."Pharmaceutical Economics Review, 12(9), 301-318.
6. Zhang, H., Murphy, TR, & Singh, K. (2022). "Clinical Pharmacokinetics thiab Industrial Applications of Advanced GLP-1 Receptor Agonist Formulations."Applied Pharmaceutical Sciences, 67(11), 445-462.